Literature DB >> 6166567

Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva.

M Tortosa, M I Cho, T J Wilkens, V J Iacono, J J Pollock.   

Abstract

Veillonella alcalescens subsp. dispar was grown in a synthetic medium containing either radiolabeled thymidine or uridine to monitor cell lysis by assay of the release of deoxyribonucleic acid or ribonucleic acid (RNA), respectively. Biochemical analyses demonstrated that, although human or hen egg white lysozymes alone did not release deoxyribonucleic acid or RNA, the nucleic acids were liberated in equal amounts from lysozyme-treated cells by the addition of low concentrations of the sodium salts of HCO-3, SCN-, Cl-, and F-, RNA release was dependent on enzyme and anion concentration. Human lysozyme was more potent than hen egg white lysozyme, and bicarbonate was the most effective anion in promoting bacteriolysis. Surprisingly, ultrastructural analyses differed from biochemical results. Lysozyme alone caused lysis in approximately 40% of the cell population. Detailed ultrastructural examination revealed aggregated cytoplasmic components which appeared as small clumps, explaining why nucleic acids were not measurable in the biochemical assays. In reaction mixtures containing lysozyme plus inorganic salts, electron microscopy results were compatible with biochemical data. Ultrastructural studies demonstrated that the addition of inorganic salts to lysozyme-treated cells resulted in the solubilization of the protoplasmic aggregates of lysed cells, presumably freeing the complexed RNA, and in the rapid lysis of the remaining cells (approximately 60%). These data suggest that electron microscopy must be used in conjunction with biochemical assays to assess lytic damage of bacterial cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166567      PMCID: PMC351588          DOI: 10.1128/iai.32.3.1261-1273.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Bacteriolysis of Enterobacteriaceae. II. Pre- and co-lytic treatments potentiating the action of lysozyme.

Authors:  E C NOLLER; S E HARTSELL
Journal:  J Bacteriol       Date:  1961-03       Impact factor: 3.490

2.  Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.

Authors:  E W Goodell; R Lopez; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  Predominant plaque flora of Tanzanian children exposed to high and low water fluoride concentrations.

Authors:  M Kilian; A Thylstrup; O Fejerskov
Journal:  Caries Res       Date:  1979       Impact factor: 4.056

4.  Lysis of certain organisms by the synergistic action of complement and lysozyme.

Authors:  H Bladen; G Hageage; R Harr; F Pollock
Journal:  J Dent Res       Date:  1973 Mar-Apr       Impact factor: 6.116

Review 5.  The normal microbial flora of the mouth.

Authors:  J M Hardie; G H Bowden
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

6.  Dental caries.

Authors:  I D Mandel
Journal:  Am Sci       Date:  1979 Nov-Dec       Impact factor: 0.548

7.  Lysozyme insensitivity of bacteria indigenous to the oral cavity of man.

Authors:  R J Gibbons; J D de Stoppelaar; L Harden
Journal:  J Dent Res       Date:  1966 May-Jun       Impact factor: 6.116

8.  Anion selectivity in biological systems.

Authors:  E M Wright; J M Diamond
Journal:  Physiol Rev       Date:  1977-01       Impact factor: 37.312

9.  The effect of osmotic shock on the accessibility of the murein layer of exponentially growing Escherichia coli to lysozyme.

Authors:  B Witholt; M Boekhout
Journal:  Biochim Biophys Acta       Date:  1978-04-04

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  6 in total

1.  Lytic sensitivity of Actinobacillus actinomycetemcomitans Y4 to lysozyme.

Authors:  V J Iacono; P R Boldt; B J MacKay; M I Cho; J J Pollock
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

2.  Effects of lysozyme and inorganic anions on the morphology of Streptococcus mutans BHT: electron microscopic examination.

Authors:  M I Cho; S C Holt; V J Iacono; J J Pollock
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

3.  Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.

Authors:  N J Laible; G R Germaine
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

4.  Bacteriolysis of Streptococcus mutans GS5 by lysozyme, proteases, and sodium thiocyanate.

Authors:  T J Wilkens; H Goodman; B J MacKay; V J Iacono; J J Pollock
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

5.  A factor from Actinomyces viscosus T14V that specifically aggregates Streptococcus sanguis H1.

Authors:  J Mizuno; J O Cisar; A E Vatter; P V Fennessey; F C McIntire
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Lysozyme-mediated aggregation and lysis of the periodontal microorganism Capnocytophaga gingivalis 2010.

Authors:  V J Iacono; S M Zove; B L Grossbard; J J Pollock; D H Fine; L S Greene
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.